James M. Billingsley, Ph.D.
Affiliations: | 2006 | Harvard University, Cambridge, MA, United States |
Area:
Immunology, Molecular BiologyGoogle:
"James Billingsley"Parents
Sign in to add mentorJean-Pierre Kinet | grad student | 2006 | Harvard | |
(FcepsilonRI ubiquitylation negatively regulates receptor tyrosine phosphorylation and mast cell effector function.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Nganou-Makamdop K, Billingsley JM, Yaffe Z, et al. (2018) Type I IFN signaling blockade by a PASylated antagonist during chronic SIV infection suppresses specific inflammatory pathways but does not alter T cell activation or virus replication. Plos Pathogens. 14: e1007246 |
Rahmberg AR, Rajakumar PA, Billingsley JM, et al. (2017) Dynamic modulation of expression of lentiviral restriction factors in primary CD4+ T cells following SIV infection. Journal of Virology |
George MD, Hu W, Billingsley JM, et al. (2014) Transcriptional profiling of peripheral CD8+T cell responses to SIVΔnef and SIVmac251 challenge reveals a link between protective immunity and induction of systemic immunoregulatory mechanisms. Virology. 468: 581-91 |
Vig M, DeHaven WI, Bird GS, et al. (2008) Defective mast cell effector functions in mice lacking the CRACM1 pore subunit of store-operated calcium release-activated calcium channels. Nature Immunology. 9: 89-96 |
Vig M, Beck A, Billingsley JM, et al. (2006) CRACM1 multimers form the ion-selective pore of the CRAC channel. Current Biology : Cb. 16: 2073-9 |
Kraft S, Fleming T, Billingsley JM, et al. (2005) Anti-CD63 antibodies suppress IgE-dependent allergic reactions in vitro and in vivo. The Journal of Experimental Medicine. 201: 385-96 |
On M, Billingsley JM, Jouvin MH, et al. (2004) Molecular dissection of the FcRbeta signaling amplifier. The Journal of Biological Chemistry. 279: 45782-90 |
Hay CM, Ruhl DJ, Basgoz NO, et al. (1999) Lack of viral escape and defective in vivo activation of human immunodeficiency virus type 1-specific cytotoxic T lymphocytes in rapidly progressive infection. Journal of Virology. 73: 5509-19 |
Rosenberg ES, Billingsley JM, Caliendo AM, et al. (1997) Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia. Science (New York, N.Y.). 278: 1447-50 |